UNI-ASIA Logo WATA Logo

Huang Wenhui | Oncology Expert in Precision Minimally Invasive Cancer Treatment in China

Huang Wenhui Appointment
Huang Wenhui
Attending Physician
Physician of Ward II, Chengdu Uni-Asia Cancer Hospital
Years of clinical experience in Medical Oncology
Served more than 25,000 patients in total
Specialties:
Specializes in individualized comprehensive diagnosis and treatment of malignant tumors, including comprehensive management of common solid tumors such as lung cancer, gastric cancer, colorectal cancer, liver cancer, esophageal cancer, breast cancer, gynecological tumors, head and neck tumors and systemic metastatic carcinoma. Has years of frontline clinical experience in medical oncology, prioritizes appropriate treatment modalities based on each patient’s tumor condition. Clinically proficient in chemotherapy, targeted therapy, immunotherapy and radiotherapy. Skilled in standardized management of adverse reactions arising from radiotherapy, chemotherapy, immunotherapy and targeted therapy with full-cycle patient care. Attaches great importance to full-disease-cycle management, and adopts integrated traditional Chinese and Western medicine combined with tumor nutrition for adjuvant conditioning.
Treatment Technologies
Providing targeted, world-class precision treatment solutions for patients worldwide.
More Treatments
Transarterial Chemoembolization (TACE)
It is primarily used for the palliative treatment of intermediate to advanced-stage primary liver cancer, liver metastases, and hypervascular tumors in areas such as the head, neck, and lungs. It can also be used as postoperative adjuvant chemotherapy to help reduce the risk of local recurrence.
NanoKnife Ablation Technology
It is primarily indicated for solid tumors located in anatomically complex regions adjacent to major blood vessels, bile ducts, pancreatic ducts, the intestines, or nerves—such as locally advanced pancreatic cancer, hilar hepatic tumors, renal hilar tumors, and prostate cancer. This technique offers a safe and effective option for curative or cytoreductive treatment in patients with unresectable lesions or tumors unsuitable for conventional thermal ablation.
Iodine-125 Seed Implantation Technology
It is primarily indicated for solid tumors that are unresectable, recurrent, or metastatic after radiotherapy and chemotherapy, including primary liver cancer, non-small cell lung cancer, prostate cancer, and pancreatic cancer, as well as recurrent or metastatic tumors of the head and neck and pelvic regions.
Argon-Helium Knife Ablation Therapy
It is widely used in the treatment of liver cancer, lung cancer, renal cancer, as well as bone and soft tissue tumors. The technique is particularly suitable for lesions adjacent to the thoracic or abdominal wall, adrenal glands, and multiple metastatic tumors, making it an important component of the minimally invasive ablation system for solid tumors.
Patient stories
At UNI-ASIA Cancer Hospital, every journey in search of care is marked by courage and hope, and every story bears witness to doctors and patients working together to overcome disease.
More Cases
Mr.Wang
Liver Cancer
Mr.Wang
China
A 71-year-old Chinese patient was diagnosed with liver cancer. Because the tumor was adjacent to major blood vessels and the patient was elderly and physically weak, he visited multiple hospitals over three years and was repeatedly told that surgery was not possible and that he could not tolerate chemotherapy. No effective treatment options remained. After being referred to Uni-Asia Cancer Hospital, he underwent three sessions of transarterial chemoembolization (TACE). He recovered smoothly after the procedures, and follow-up examinations showed that the tumor had almost disappeared, achieving clinical cure. He has now returned to his orchard and resumed normal life.
Wang Xiaocai
Lung Cancer
Wang Xiaocai
China
Chinese patient, diagnosed with stage IIIb lung adenocarcinoma with hilar, mediastinal, and cervical lymph node metastasis. Due to the deep and multiple locations of the tumors, and because the patient experienced no subjective symptoms, he feared open surgery and the side effects of chemotherapy and refused conventional treatment. After referral to Uni-Asia Cancer Hospital, he underwent transarterial chemoembolization (TACE) of the tumor-feeding arteries. He was able to get out of bed the day after the procedure, recovered well, has since returned to normal life, and is awaiting subsequent cycles of treatment.
Liu Heyi
Liver Cancer
Liu Heyi
China
A Chinese patient was diagnosed with liver cancer accompanied by severe bile duct obstruction, severe systemic jaundice, and a weight loss of nearly 15 kg within one month. His bilirubin level was as high as 257.50 umol/L. Because the tumor was adjacent to major blood vessels, several hospitals assessed that surgical resection would carry an excessively high risk. After being referred to UNI-ASIA Cancer Hospital, he underwent two interventional treatments. He recovered quickly after the procedures, was able to get out of bed the next day, his jaundice subsided, his weight stabilized, and he has now returned to normal life.
Chen De
Bladder Cancer
Chen De
China
A Chinese patient presented with recurrent bladder cancer six years after initial surgery, accompanied by liver metastasis and abdominal aortic thrombosis. The MDT at West China Hospital recommended radical cystectomy, but the patient declined due to concerns about his physical condition. After undergoing interventional therapy at our hospital, his demeanor shifted markedly — from withdrawn and largely silent before treatment to actively engaging in conversation with his family afterward. His pain has lessened, and he now awaits the next cycle of treatment with renewed confidence.

Consultation

Consultation Type
Name
Gender
Age
Nationality
Phone Number
Email
Your Question
Privacy Policy and Statement

Submitted Successfully

We have received your consultation. Thank you for your trust. A specialist will contact you within 72 hours, so please keep an eye on your phone calls and email.
Book Appt. WhatsApp
Call Us